Why a cancer diagnosis is only as good as the second look

WHY A CANCER DIAGNOSIS IS ONLY AS GOOD AS THE SECOND LOOK About 18 million girls in Nigeria have now received the HPV vaccine. That was one of the most encouraging figures to come out of International Cancer Week (ICW) 2026. But the same panel was clear that vaccination is only the first step. Real progress depends on what happens after detection. Our team attended ICW at the NAF Conference Centre in Abuja, where the National Institute for Cancer Research and Treatment (NICRAT) brought together researchers, clinicians and policymakers under the theme “United Against Cancer.” Across the sessions we attended, three ideas stood out. ACCURATE DIAGNOSIS COMES BEFORE EVERYTHING ELSE Speakers from Nigeria’s research and laboratory community returned again and again to quality: well-handled samples, accredited laboratories, trained specialists and reliable results. Treatment decisions are only as sound as the diagnosis they rest on. When the result is wrong or unclear, everything downstream is affected. Detection only saves lives if something happens next The panel on eliminating cervical cancer made a point we found striking. Isolated screening efforts, however well-intentioned, will not eliminate the disease. Screening has to sit inside an organised system, and every positive result needs a clear route to follow-up and treatment. As one principle put it, an organisation that cannot provide that pathway should partner with one that can, rather than leave patients with a result and no next step. CONFIRMATION BEATS ASSUMPTION A talk on antimicrobial resistance and cancer made a similar case from a clinical angle. When clinicians assume a patient cannot afford confirmatory testing and treat without it, outcomes can suffer and costs can rise. Testing early and acting on the results is often cheaper than a long trial of different treatments. WHAT THIS MEANS FOR DOCTORS AND PATIENTS Taken together, these sessions describe one need: a result that is accurate, clearly explained and acted on. A scan or biopsy is only the start. What matters is whether the right specialist reviews it and whether the doctor and patient understand the answer. That is the problem MedSecOp works on. A referring doctor sends existing scans, or biopsy tissue or slides, with brief clinical notes. A verified radiologist or pathologist, in Nigeria or abroad, reviews them. The doctor receives the specialist report, and the patient receives a plain-language explanation. The process typically takes five to seven working days. We review existing scans and biopsy samples only and do not run new tests, so the focus stays on one thing: a second expert opinion and no result left unexplained. BETTER CANCER CARE STARTS WITH STRONGER LINKS ICW reinforced our conviction that better cancer care in Nigeria will come from stronger links between doctors, laboratories and specialists. A scan or biopsy should never leave a doctor or patient with unanswered questions. Are you a doctor who wants a trusted second opinion on your patients’ scans or biopsy samples, a patient seeking clarity, or a radiologist or pathologist who would like to contribute your expertise? Email us at contact@medsecop.com or visit medsecop.com to see how it works.